Would you like to know more about our scientific progress in 2021?
We've put it all together in the BPRC Annual Scientific Report. You will find the scientific highlights in 2021, the financial results and the facts & figures.
Would you like to know more about our scientific progress in 2021?
We've put it all together in the BPRC Annual Scientific Report. You will find the scientific highlights in 2021, the financial results and the facts & figures.
Within the Biomedical Primate Research Centre (BPRC) there is a profound interest in the development of animal-free innovations. We developed a large variety of bioassays, which also turned out useful for research into multiple sclerosis involving experimental animals.
COVID-19 has many faces. While one person just has a runny nose, the other gets really sick. Also, some suffer from the long-term consequences of SARS-CoV-2 infection, such as persistent fatigue and shortness of breath. Even after mild infection.
Adenoviruses are the causative agents of the common cold, and are relatively harmless. They are also widely used as vectors for the production of vaccines, amongst which vaccines against SARS-CoV-2.
Researchers at the University of Groningen collaborating with researchers of the alternatives unit of BPRC, have characterized a specific brain cell type in different animal species in great detail. They have focused on microglia. These cells are often referred to as macrophages of the brain and have many important functions, both in the healthy brain as well as during neurological diseases.
World Immunization Week is from April 24 to April 30. With the slogan "vaccines bring us closer together", the WHO draws attention to vaccinations.
In much of the world, malaria continues to cause high mortality, especially among children. In adults who have survived the various attacks of the malaria parasite on the body, the immune system is trained and can increasingly recognize and neutralize the great diversity of malaria parasites. BPRC scientists investigated whether a vaccine can give the same immune response.
Parkinson's disease is the fastest growing brain disorder worldwide. This is partly due to the increasing age of the population, but also in younger age groups the incidence is rising. In 5% of cases there is an hereditary cause, but for the vast majority of patients the cause is unknown. To combat Parkinson's disease, collaboration is important.
On March 17, 2020, BPRC received permission from the Central Animal Experiments Committee for COVID-19 work. Today, exactly a year later, our monkeys collaborated on twelve vaccines and one drug.